Mesenchymal Stem Cell-Mediated Immunosuppression Occurs via Concerted Action of Chemokines and Nitric Oxide
Top Cited Papers
- 1 February 2008
- journal article
- Published by Elsevier in Cell Stem Cell
- Vol. 2 (2) , 141-150
- https://doi.org/10.1016/j.stem.2007.11.014
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- The role of IL-6 in inhibition of lymphocyte apoptosis by mesenchymal stem cellsBiochemical and Biophysical Research Communications, 2007
- Concise Review: Mesenchymal Stem Cells: Their Phenotype, Differentiation Capacity, Immunological Features, and Potential for HomingThe International Journal of Cell Cloning, 2007
- Stem cell sources for clinical islet transplantation in type 1 diabetes: Embryonic and adult stem cellsMedical Hypotheses, 2006
- Selective targeting of the LIGHT-HVEM costimulatory system for the treatment of graft-versus-host diseaseBlood, 2006
- Mesenchymal stromal cellsCurrent Opinion in Hematology, 2006
- Monocyte Chemotactic Protein-3 Is a Myocardial Mesenchymal Stem Cell Homing FactorThe International Journal of Cell Cloning, 2006
- Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative settingBlood, 2006
- Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergyBlood, 2005
- Cross reactivity of three T cell attracting murine chemokines stimulating the CXC chemokine receptor CXCR3 and their induction in cultured cells and during allograft rejectionEuropean Journal of Immunology, 2001
- Lymphocyte-specific chemokine receptor CXCR3: regulation, chemokine binding and gene localizationEuropean Journal of Immunology, 1998